Novel etomidate derivatives

Current Pharmaceutical Design

Volumn 18, Issue 38, 2012, Pages 6253-6256

  Sneyd, J Robert ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Carboetomidate; Etomidate; Midazolam; MOC carboetomidate; MOC etomidate; Propofol

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CARBOETOMIDATE; CORTICOTROPIN; ETOMIDATE; LIPID; METHOXYCARBONYL CARBOETOMIDATE; METHOXYCARBONYL ETOMIDATE; MIDAZOLAM; PROPOFOL; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ANESTHESIA; CLINICAL PRACTICE; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; HUMAN; MYOCLONUS; NONHUMAN; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; REVIEW;

ANESTHETICS, INTRAVENOUS; ANIMALS; DRUG DESIGN; ETOMIDATE; HUMANS; HYDROLYSIS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84873968794     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212803832362     Document Type: Review

References (25)

1. Ledingham IMA, Finlay WEI, et al. Etomidate and adrenocortical function. The Lancet 1983; 321(8339): 1434.
2. Albert SG, Ariyan S, Rather A. The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med 2011; 37(6): 901-10.
3. Bendel S, Ruokonen E, Polonen P, Uusaro A. Propofol causes more hypotension than etomidate in patients with severe aortic stenosis: a double-blind, randomized study comparing propofol and etomidate. Acta Anaesthesiol Scand 2007; 51(3): 284-9.
4. Jabre P, Combes X, Lapostolle F, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 2009; 374(9686): 293-300.
5. Cotten JF, Husain SS, Forman SA, et al. Methoxycarbonyletomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression. Anesthesiology 2009; 111(2): 240-9.
6. Vijn PC, Sneyd JR. I.v. anaesthesia and EEG burst suppression in rats: bolus injections and closed-loop infusions. british journal of anaesthesia 1998; 81(3): 415-21.
7. Cotten JF, Le Ge R, Banacos N, et al. Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function. Anesthesiology 2011; 115(4): 764-73.
8. Ge RL, Pejo E, Haburcak M, Husain SS, Forman SA, Raines DE. Pharmacological Studies of Methoxycarbonyl Etomidate's Carboxylic Acid Metabolite. Anesth Analg 2011.
9. Egan TD. Is anesthesiology going soft?: trends in fragile pharmacology. Anesthesiology 2009; 111(2): 229-30.
10. Sneyd JR, Rigby-Jones AE. New drugs and technologies, intravenous anaesthesia is on the move (again). Br J Anaesth 2010; 105(3): 246-54.
11. Pitsiu M, Wilmer A, Bodenham A, et al. Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment. Br J Anaesth 2004; 92(4): 493-503.
12. Dabbagh A, Sa'adat N, Heidari Z. Etomidate infusion in the critical care setting for suppressing the acute phase of Cushing's syndrome. Anesth Analg 2009; 108(1): 238-9.
13. Pejo E, Cotten JF, Kelly EW, et al. In vivo and In vitro Pharmacological Studies of Methoxycarbonyl-Carboetomidate. Anesth Analg 2011 Nov 14.
14. Pejo E, Feng Y, Chao W, Cotten JF, Le Ge R, Raines DE. Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia. Crit Care Med 2011 Sep 15.
15. Sneyd JR. Recent advances in intravenous anaesthesia. Br J Anaesth 2004; 93(5): 725-36.
16. Reddy RV, Moorthy SS, Dierdorf SF, Deitch Rd Jr, Link L. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesthesia and Analgesia 1993; 77: 1008-11.
17. Sneyd JR. Excitatory events associated with propofol anaesthesia: a review. J Royal Society Med 1992; 85(5): 288-91.
18. Sneyd JR, Wright PM, Harris D, et al. Computer-controlled infusion of ORG 21465, a water soluble steroid i.v. anaesthetic agent, into human volunteers. British Journal of Anaesthesia 1997; 79(4): 433-9.
19. Gan TJ, Glass PS, Howell ST, Canada AT, Grant AP, Ginsberg B. Determination of plasma concentrations of propofol associated with 50% reduction in postoperative nausea. Anesthesiology 1997; 87(4): 779-84.
20. Forman SA. Clinical and Molecular Pharmacology of Etomidate. Anesthesiology 2011; 114(3): 695-707.
21. Rigby-Jones AE, Sneyd JR, Ravenelle F, et al. Pharmacokinetics and anaesthetic effects of propofol-PM: a novel water soluble propofol formulation. Anaesthesia 2008; 63(12): 1392-3.
22. Ravenelle F, Vachon P, Rigby-Jones AE, et al. Anaesthetic effects of propofol polymeric micelle: a novel water soluble propofol formulation. British Journal of Anaesthesia 2008; 101(2): 186-93.
23. Kilpatrick GJ, McIntyre MS, Lovell GG, Wiard RP, Feldman PL, Tilbrook GS. CNS 7056: A Novel Ultra-Short-Acting Benzodiazepine. Anesthesiology 2007; 107: 60-6.
24. Rigby-Jones AE, Sneyd JR, Vijn P, Boen P, Cross M. First administration to man of Org 25435, an intravenous anaesthetic: A Phase 1 Clinical Trial. BMC Anesthesiol 2010; 10: 10.
25. Husain SS, Stewart D, Desai R, et al. p-Trifluoromethyldiazirinyletomidate: A Potent Photoreactive General Anesthetic Derivative of Etomidate That Is Selective for Ligand-Gated Cationic Ion Channels. J Med Chem 2010; 53(17): 6432-44.